Parexel appoints Jim Anthony as CCO and President, Parexel Biotech
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
This acquisition expands HGM's healthcare platform capabilities in revenue cycle management
Its lead product, Dasynoc, is awaiting FDA approval with a PDUFA date of October 7, 2025
Alkem’s domestic business grew 9.7 per cent versus the Indian pharmaceutical market growth of 8.5 per cent
Reinforcing commitment to ethical and sustainable growth
The agreement complements other PPAs for Sandoz production sites globally
NJ Bio is currently executing a major new program for an existing innovator customer with multiple ADC candidates in their pipeline
Cupid reported total income of Rs. 64.75 crore in Q1 FY26 as compared to Rs. 44.03 crore in Q1 Fy25
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
Subscribe To Our Newsletter & Stay Updated